Skip to main content
. 2021 Aug 30;2021:3471764. doi: 10.1155/2021/3471764

Table 1.

Univariate analysis of influencing the occurrence of ALI in patients.

Variables n The limb ischemia group (n = 16) The nonlimb ischemia group (n = 108) P
Age (year) 124 54.31 ± 11.75 58.63 ± 13.91 0.236
Proportion of female (%) 37 4 (25.00%) 33 (30.56%) 0.651
BMI (kg/m2) 124 24.32 ± 2.95 23.40 ± 2.54 0.194
Hypertension (%) 49 5 (31.25) 44 (40.74) 0.469
Diabetes (%) 25 2 (12.50) 23 (21.30) 0.413
Hyperlipidemia (%) 5 2 (12.50) 3 (2.78) 0.065
Long history of oral anticoagulants (%) 10 0 (0.00) 10 (9.26) 0.204
History of myocardial infarction (%) 9 0 (0.00) 9 (8.33) 0.231
Smoking history (%) 32 9 (56.25) 23 (21.30) 0.003
History of COPD (%) 1 0 (0.00) 1 (0.93) 0.699
History of chronic kidney disease (%) 2 0 (0.00) 2 (1.85) 0.583
Cardiac arrest (%) 81 12 (75.00) 69 (63.89) 0.383
ECMO catheterization method 0.479
Prepositioned (%) 6 0 (0.00) 6 (5.56)
Percutaneous puncture (%) 105 13 (81.25) 92 (85.19)
Incision (%) 3 1 (6.25) 2 (1.85)
Puncture + incision (%) 10 2 (12.50) 8 (7.41)
Drainage tube model (F) 124 22.00 (16.00, 18.00) 21.00 (15.00, 24.00) 0.089
Perfusion tube model (F) 124 16.00 (16.00, 18.00) 16.00 (15.00, 23.00) 0.245
Drainage-perfusion tube ipsilateral (%) 64 7 (43.75) 57 (52.78) 0.501
Distal perfusion tube DPC (%) 43 6 (37.50) 37 (34.26) 0.799
ECMO first auxiliary time (h) 124 115.00 (52.40, 192.30) 78.10 (0.50, 405.90) 0.085
Live out of the hospital (%) 68 10 (62.50) 58 (53.70) 0.509
Acute stroke (%) 6 0 (0.00) 6 (5.56) 0.334
Hyperbilirubinemia (%) 63 10 (62.50) 53 (49.07) 0.316